Discuss This Drug

tasimelteon

CHEBI:CHEBI_79042

Definition

A member of the class of 1-benzofurans that is propionamide in which one of the amide hydrogens is replaced by a [(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl group. A melatonin receptor agonist used for the treatment of non-24-hour sleep-wake disorder.

Chemical Information

Molecular Formula
C15H19NO2
Molecular Mass
245.31690
Charge
0
SMILES
CCC(=O)NC[C@@H]1C[C@H]1c1cccc2OCCc12
InChI
InChI=1S/C15H19NO2/c1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/h3-5,10,13H,2,6-9H2,1H3,(H,16,17)/t10-,13+/m0/s1
InChIKey
PTOIAAWZLUQTIO-GXFFZTMASA-N

Alternative Names

  • BMS 214778
  • BMS-214778
  • Hetlioz
  • N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide
  • tasimelteon
  • tasimelteonum
  • VEC 162
  • VEC-162

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:79042
DRON_00010000
1490468
oboInOwl#hasDbXref
Wikipedia:Tasimelteon

Additional References

Wikipedia:Tasimelteon

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

core#notation
CHEBI:79042
rxcui
2468316
active_ingredient_strength
1 kg/kg
nui
N0000000250
pharm_class_epc
Melatonin Receptor Agonist [EPC]
pharm_class
Melatonin Receptor Agonists [MoA]
pharm_class_moa
Melatonin Receptor Agonists [MoA]
package_marketing_start_date
04-APR-14
manufacturer_name
Apotex Corp.
active_ingredient_name
TASIMELTEON
package_description
1 BOTTLE in 1 CARTON (43068-304-06) / 158 mL in 1 BOTTLE
unii
SHS4PU80D9
spl_set_id
ca4a9b63-708e-49e9-8f9b-010625443b90
upc
0369238254839
package_ndc
67651-0307-0
brand_name_suffix
LQ
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect35494
owl#annotatedSource
t300660
owl#someValuesFrom
t3865829
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
1490468
oboInOwl#hasDbXref
Wikipedia:Tasimelteon
oboInOwl#id
CHEBI:79042
brand_name
Hetlioz LQ
brand_name_base
Tasimelteon
generic_name
TASIMELTEON
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
listing_expiration_date
20241231
route
ORAL
dosage_form
SUSPENSION
marketing_start_date
20140404
labeler_name
Apotex Corp.
product_ndc
43068-304
application_number
NDA214517
spl_id
3248eef5-6bad-4844-a6f9-2f5fddd39c8d
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_45422
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_79046